SAN FRANCISCO & PARIS--(BUSINESS WIRE)--SpineGuard announced today that it has received regulatory approval from the Roszdravnadzor, the Russian healthcare agency that oversees medical devices, to market PediGuard in Russia.
SpineGuard further announced that it is partnering with Moscow-based Multi-Systems Technology ("MST") to sell PediGuard in Russia. MST has an extensive network of 53 distributors across Russia - from Kaliningrad in the west across seven time zones to Khabarovsk in the Russian Far East. MST specializes in products for neurosurgery, spine surgery, trauma and orthopedics.
"This regulatory clearance is the result of a very effective collaboration with MST, which is promising for the adoption of PediGuard in Russia," said Pierre Jérôme, Co-founder and Chief Executive Officer of SpineGuard. "I am of course delighted that Russian spine surgeons and their patients can now benefit from PediGuard, whose value in pedicle screw placement accuracy has been dramatically demonstrated in several peer-reviewed medical journals."
PediGuard® has been used in more than 24,000 procedures in over 40 countries. There are approximately 300 spine surgeons who are now using PediGuard on a regular basis.
Co-founded in 2009 by Pierre Jérôme and Stéphane Bette, former executives at Medtronic Sofamor-Danek and SpineVision, SpineGuard's mission is to make spine surgery safer. For further information, visit www.spineguard.com.